Dr. Borson is a clinician-researcher and health system consultant working to improve dementia detection and care across health systems, communities, and public health settings. She created the Mini-Cog to support widespread access to early detection. She is now working to develop "Six Domains of Health", a whole-person, whole-family, whole-community framework to promote unified, cross-sector activation, training, and goal-setting for better dementia outcomes.

Joshua Chodosh, MD, MSHS, FACP (he/him), is Director of the Division of Geriatrics and Palliative Care at NYU Langone, where he is dedicated to enhancing the quality of care for older adults and individuals requiring compassionate support. Guided by a belief that even simple solutions can significantly improve patient outcomes, Dr. Chodosh focuses on delivering personalized, effective care that addresses the complexities of aging. A geriatrics specialist, Dr. Chodosh has expertise in dementia detection, cognitive health, and functional disabilities, as well as in managing conditions such as sleep disorders and hearing loss. His work also explores the integration of technology in healthcare, with a particular emphasis on advancing innovative strategies for the early detection and management of dementia. Dr. Chodosh leads several major national initiatives, including the Centers for Disease Control and Prevention’s BOLD Public Health Center of Excellence on Early Detection of Dementia and the National Institutes of Health–funded ED-LEAD study, which seeks to transform emergency and post-discharge care for individuals living with dementia. These efforts reflect his commitment to advancing both the science and delivery of care for older adults. With an unconventional path into medicine that began in carpentry and cabinetmaking, Dr. Chodosh brings a unique perspective to his clinical and research work. Recruited from UCLA to NYU Langone, he established the Michael L. Freedman Research Center on Aging, Technology, and Cognitive Health and continues to lead interdisciplinary efforts to improve outcomes for older adults through innovation and collaboration.

Dr. Brangman is a SUNY Distinguished Service Professor and Chair of the Department of Geriatrics at SUNY Upstate Medical University. Prior to this appointment, she had been the Division Chief of Geriatrics for 20 years. Dr. Brangman is director of the Upstate Center of Excellence for Alzheimer’s Disease. Dr. Brangman is a trustee of the McKnight Brain Research Foundation. She is also a past President and Chair of the Board of both the American Geriatrics Society, and the Association of Geriatric Academic Program Directors.

Suzanne E. Schindler, MD, PhD, is a neurologist and neuroscientist dedicated to advancing the diagnosis and treatment of Alzheimer’s disease. She cares for patients with memory concerns at the Washington University Memory Diagnostic Center, where she also coordinates the collection and analysis of real-world data on Alzheimer’s biomarkers and amyloid-targeted therapies. Dr. Schindler leads the Fluid Biomarker Core of the Knight Alzheimer’s Disease Research Center and has facilitated numerous collaborative studies, including those that developed and validated some of the first clinically available blood tests for Alzheimer’s disease pathology. She has evaluated the generalizability of AD biomarkers across diverse groups, led head-to-head comparisons of Alzheimer’s blood tests, studied the timing of key events in the disease, and co-led the creation of consensus recommendations for the performance of clinical Alzheimer’s blood tests. An active educator, she trains clinicians to integrate Alzheimer’s biomarkers into their evaluations of patients with cognitive impairment.

Stephanie Ruth Young, PhD is an early-stage investigator, licensed psychologist, and Assistant Professor in Medical Social Sciences at Northwestern University Feinberg School of Medicine. Her expertise spans digital cognitive assessment, psychometrics, and clinical implementation, with research focused on developing and validating neuropsychological tools to improve health outcomes in older adults. Dr. Young leads and collaborates on multiple NIH-funded projects advancing the early detection of cognitive impairment through digital technologies, including serving as the MPI of the MyCog Trial (U01NS105562) and as a co-investigator on the Toolbox Detect, MyCog Mobile, and Mobile Toolbox grants. She also leads the design and validation of MyCog Mobile, a smartphone-based cognitive screener that enables older adults to self-administer assessments at home prior to primary care visits, with integrated electronic health record decision support.